Get started
Author

Christine Ardito-Abraham

Observed names: Ardito-Abraham, Christine, C Ardito, C. Ardito-Abraham, Christine M Ardito, Christine M Ardito‐Abraham, Christine M. Ardito, Christine M. Ardito-Abraham, Christine M. Ardito, Christine M. Ardito-Abraham
ORCID: 0000-0002-2824-7019
Observed ORCID: 0000-0002-2824-7019
OpenAlex ID: A5026829947
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
2014 · Sylvia F. Boj, Chang-Il Hwang, et al. · Cell · 2,146
PDF
EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
2012 · Christine M. Ardito, Barbara M. Grüner, et al. · Cancer Cell · 518
Molecular determinants of sotorasib clinical efficacy in KRASG12C-mutated non-small-cell lung cancer
2025 · Ferdinandos Skoulidis, Bob T. Li, et al. · Nature Medicine · 50
PDF
Identification of novel vascular projections with cellular trafficking abilities on the microvasculature of pancreatic ductal adenocarcinoma
2015 · Hexige Saiyin, Christine M Ardito‐Abraham, et al. · The Journal of Pathology · 38
Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer
2025 · Ferdinandos Skoulidis, Bob T Li, et al. · The Oncologist · 12
PDF
Targeting of extracellular proteases required for the progression of pancreatic cancer
2008 · Christine M Ardito, Courtney D Briggs, et al. · Expert Opinion on Therapeutic Targets · 11
Abstract 3036: Real-time genomic characterization of metastatic pancreatic cancer to enable precision medicine
2017 · Andrew J. Aguirre, Scott Carter, et al. · Cancer Research · 2
Sotorasib in Advanced KRAS G12C-Mutated NSCLC: Results From the Global Expanded Access Program, Including Patients With Poor Performance Status and a History of CNS Metastases
2026 · Silvia Novello, Natalie Maimon Rabinovich, et al. · JTO Clinical and Research Reports · 1
P3.12E.04 Long-Term Outcomes with Sotorasib in KRAS G12c-Mutated Advanced NSCLC from the Global Expanded Access Program (EAP) Study-436
2024 · S. Novello, N. Maimon, et al. · Journal of Thoracic Oncology · 1
PDF
Abstract B16: Using human patient-derived organoids to identify genetic dependencies in pancreatic cancer
2016 · Lindsey A. Baker, Hervé Tiriac, et al. · Clinical Cancer Research · 1
58P Real-world intracranial effectiveness of sotorasib in second-line (2L) and beyond (2L+) treatment (tx) of KRAS G12C-mutated non-small cell lung cancer (NSCLC) with brain metastases (BM)
2026 · E. Nadal, J. Sabari, et al. · ESMO Open
PP01.17 Sotorasib in Advanced KRAS p.G12C–Mutated NSCLC with Treated or Untreated Brain Metastases: Safety and Efficacy Data from the Global Expanded Access Program (EAP)
2023 · M.M. Awad, G. Pelizzari, et al. · Journal of Thoracic Oncology
PDF
Abstract A77: Investigating the role of ADAM10 in pancreatic tumor differentiation
2015 · Louise V. Peverley, Christopher J. Halbrook, et al. · Cancer Research
194 Pancreatic ductal organoids as a new platform for drug discovery
2014 · M. Ponz-Sarvise, V. Corbo, et al. · European Journal of Cancer
EGF Rezeptor signaling ist obligatorisch für die Kras-induzierte Entwicklung des Pankreaskarzinoms
2012 · B Grüner, C Ardito, et al. · Zeitschrift für Gastroenterologie
Abstract B84: EGFR activation by the ADAM17 sheddase is required for Kras-induced pancreatic tumorigenesis.
2012 · Christopher J. Halbrook, Kenneth K. Takeuchi, et al. · Tumor Biology
ADAM10 and ADAM17 regulate various stages of pancreatic disease
2011 · Christine M. Ardito · Academic Commons (Stony Brook University)
Works count: 18
Citation count: 2,780
H-index: 6
I10-index: 6
Year
Topic
Type